These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18281372)

  • 1. Tumour necrosis factor alpha upregulates platelet CD40L in patients with heart failure.
    Pignatelli P; Cangemi R; Celestini A; Carnevale R; Polimeni L; Martini A; Ferro D; Loffredo L; Violi F
    Cardiovasc Res; 2008 Jun; 78(3):515-22. PubMed ID: 18281372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascorbic acid infusion blunts CD40L upregulation in patients undergoing coronary stent.
    Pignatelli P; Tanzilli G; Carnevale R; Di Santo S; Loffredo L; Celestini A; Proietti M; Tovaglia P; Mangieri E; Basili S; Violi F
    Cardiovasc Ther; 2011 Dec; 29(6):385-94. PubMed ID: 20629665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gp91phox-dependent expression of platelet CD40 ligand.
    Pignatelli P; Sanguigni V; Lenti L; Ferro D; Finocchi A; Rossi P; Violi F
    Circulation; 2004 Sep; 110(10):1326-9. PubMed ID: 15249506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
    Choudhury A; Chung I; Panja N; Patel J; Lip GYH
    Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia.
    Sanguigni V; Ferro D; Pignatelli P; Del Ben M; Nadia T; Saliola M; Sorge R; Violi F
    J Am Coll Cardiol; 2005 Jan; 45(1):35-42. PubMed ID: 15629370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative levels of the inflammatory cytokine TNFα and the soluble CD40 ligand profile in serum correlate with the thyrotoxic activity of Graves' disease.
    Yamamoto K; Itoh M; Okamura T; Kimura M; Yokoyama A; Yoshino Y; Makino M; Hayakawa N; Suzuki A
    Thyroid; 2012 May; 22(5):516-21. PubMed ID: 22512415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin.
    Pignatelli P; Sanguigni V; Lenti L; Loffredo L; Carnevale R; Sorge R; Violi F
    J Thromb Haemost; 2007 Jun; 5(6):1170-8. PubMed ID: 17388962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
    Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O2- production.
    De Biase L; Pignatelli P; Lenti L; Tocci G; Piccioni F; Riondino S; Pulcinelli FM; Rubattu S; Volpe M; Violi F
    Thromb Haemost; 2003 Aug; 90(2):317-25. PubMed ID: 12888880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
    Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
    Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization.
    Furman MI; Krueger LA; Linden MD; Barnard MR; Frelinger AL; Michelson AD
    J Am Coll Cardiol; 2004 Jun; 43(12):2319-25. PubMed ID: 15193700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin Reduces the Potentiating Effect of CD40L on Platelet Aggregation via Inhibition of Myosin Light Chain.
    Kojok K; Mohsen M; El Kadiry AEH; Mourad W; Merhi Y
    J Am Heart Assoc; 2020 Feb; 9(3):e013396. PubMed ID: 32009527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
    Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
    Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity.
    Chung I; Choudhury A; Patel J; Lip GY
    J Intern Med; 2008 Mar; 263(3):313-21. PubMed ID: 18086125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation with no effect of aspirin intake.
    Giannini S; Falcinelli E; Bury L; Guglielmini G; Rossi R; Momi S; Gresele P
    Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2072-9. PubMed ID: 21378140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early increase of oxidative stress and soluble CD40L in children with hypercholesterolemia.
    Martino F; Pignatelli P; Martino E; Morrone F; Carnevale R; Di Santo S; Buchetti B; Loffredo L; Violi F
    J Am Coll Cardiol; 2007 May; 49(19):1974-81. PubMed ID: 17498583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane A(2) promotes soluble CD40 ligand release from human platelets.
    Enomoto Y; Adachi S; Matsushima-Nishiwaki R; Doi T; Niwa M; Akamatsu S; Tokuda H; Ogura S; Yoshimura S; Iwama T; Kozawa O
    Atherosclerosis; 2010 Apr; 209(2):415-21. PubMed ID: 19932480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.
    Danese S; Sans M; Scaldaferri F; Sgambato A; Rutella S; Cittadini A; Piqué JM; Panes J; Katz JA; Gasbarrini A; Fiocchi C
    J Immunol; 2006 Feb; 176(4):2617-24. PubMed ID: 16456024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alimentary lipemia and inflammation on platelet CD40-ligand.
    Kälsch T; Elmas E; Nguyen XD; Kralev S; Leweling H; Klüter H; Dempfle CE; Borggrefe M
    Thromb Res; 2007; 120(5):703-8. PubMed ID: 17289125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products.
    Varo N; Libby P; Nuzzo R; Italiano J; Doria A; Schönbeck U
    Diab Vasc Dis Res; 2005 May; 2(2):81-7. PubMed ID: 16308911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.